| Financial Year |
March 31 2023 |
| Monetary Funds |
146,563,648.53 |
| Held-for-trading Financial Assets |
25,160,833.34 |
| Notes Receivable |
-- |
| Accounts Receivable |
299,204,360.77 |
| Advances to Suppliers |
98,802,086.21 |
| Other Receivables |
6,110,696.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
756,805,764.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,276,242.80 |
| Total Current Assets |
1,388,282,250.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,206,446.81 |
| Fixed Assetes |
207,312,963.96 |
| Under-construction Projects |
5,076,939.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,681,825.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,592,301.39 |
| Deferred Income Tax Assets |
26,233,788.59 |
| Other Non-Current Assets |
1,802,211.58 |
| Sub-Total of Non-Current Assets |
299,709,408.16 |
| Total Assets |
1,687,991,658.79 |
| Short-Term Loans |
59,542,075.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
204,440,638.66 |
| Accounts Payable |
120,568,017.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,737,336.76 |
| Taxes Payable |
1,541,802.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,096,000.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
648,854.86 |
| Other Current Liabilities |
4,349,836.34 |
| Sub-Total of Current Liabilities |
851,579,774.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,093,151.39 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,667,946.10 |
| Total Liabilities |
880,247,720.47 |
| Paid-In Capital(Or Share Stock) |
108,000,000.00 |
| Capital Surplus |
396,497,729.06 |
| Surplus Reserve |
36,584,856.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
261,103,924.80 |
| Minority Stockholder's Interest |
346,831.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
807,397,106.37 |
| Owner's Equity（Stockholder's Equity） |
807,743,938.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,687,991,658.79 |
